Diabetes
Conference Coverage
Tackle education and mindset to reduce diabetes distress
“Diabetes distress is the emotional response to living with diabetes, the burden of relentless daily self-management, and the prospect of its long...
Conference Coverage
‘Striking’ benefit of lipid lowering in primary prevention
“If patients can’t tolerate a statin, then treat them with bempedoic acid. The bottom line is that these patients just need to be treated.”
Conference Coverage
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
Taken together, results from SURMOUNT-1 and SURMOUNT-2 appear to make a good case for a weight-loss indication that will not depend on whether a...
Latest News
Low copays drive better adherence to new diabetes drugs
Regardless of patients’ socioeconmic status, copays were related to adherence.
Latest News
Is education or screening better for type 1 diabetes?
Despite the impressive data from the FR1DA study, not all diabetes experts are convinced that a general screening for type 1 diabetes would be...
News
FDA OKs empagliflozin for children with type 2 diabetes
This approval represents only the second oral treatment option for children and adolescents with type 2 diabetes after metformin.
Latest News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.
Latest News
Hold Ozempic before surgery to optimize patient safety?
“It’s a really hot issue now. We are getting emails from our members looking for guidance.”
Conference Coverage
A ‘one-stop shop’: New guidance on hormones and aging
Part of what we need to do is [provide] the evidence that we have, which includes evidence of when not to prescribe as well as [when] to prescribe...
News
Depression drives metabolic syndrome
The association between baseline depression and development of metabolic syndrome was strongest for those with severe depression.